Dr. Denise Galloway

For the Media

Dr. Denise Galloway

Dr. Denise Galloway is the associate director of the Human Biology Division and a member of the Public Health Sciences Division. She is also director of Fred Hutch's Pathogen-Associated Malignancies Integrated Research CenterEarly in her career, Dr. Galloway became fascinated by the idea that a virus could lead to cancer by sparking changes within cells. This idea led her to study the human papilloma virus (HPV) and to make breakthrough contributions to a vaccine that prevents HPV and averts tens of thousands of cervical cancer cases each year.

Resources for more information

  • Overview of Denise Galloway’s Research
    Working with other Fred Hutch investigators to identify viruses that might trigger a wide variety of cancers
  • Denise Galloway – Brief Curriculum Vitae
    Appointments, affiliations and researcher interests.
  • Pathogen-Associated Malignancies Integrated Research Center
    The Pathogen-Associated Malignancies IRC brings together Hutch experts in infectious diseases, host-pathogen interactions, cancer biology, immunology, global oncology and immunotherapy to understand, treat and prevent the cancers linked to infectious agents.
  • The Galloway Lab
    Focus is on the mechanisms by which human papillomaviruses contribute to cancer, with an emphasis on types most likely to progress to cervical cancer. They work to understand the natural history of genital HPV infections and why only a small subset of women infected with high-risk HPVs develop cancer. 
  • Human Biology
    Grounded in high-quality basic science, the research performed in Human Biology blends fundamental, applied, and translational research performed in model organisms and in vitro systems.

FOR THE MEDIA

Hutch Team

For more information or to arrange an interview, please contact Fred Hutch at (206) 667-2210 or email our media relations team.


 

Photos / Graphics / Video

Download

Download photos and view video of Denise Galloway.

Related Stories


At Fred Hutchinson Cancer Research Center, home to three Nobel laureates, interdisciplinary teams of world-renowned scientists seek new and innovative ways to prevent, diagnose and treat cancer, HIV/AIDS and other life-threatening diseases. Fred Hutch’s pioneering work in bone marrow transplantation led to the development of immunotherapy, which harnesses the power of the immune system to treat cancer with minimal side effects. An independent, nonprofit research institute based in Seattle, Fred Hutch houses the nation’s first and largest cancer prevention research program, as well as the clinical coordinating center of the Women’s Health Initiative and the international headquarters of the HIV Vaccine Trials Network. Private contributions are essential for enabling Fred Hutch scientists to explore novel research opportunities that lead to important medical breakthroughs. For more information visit fredhutch.org or follow Fred Hutch on Facebook, Twitter or YouTube.